E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/30/2021 in the Prospect News High Yield Daily.

China Evergrande notes dive; Peabody stronger; Washington Prime flat; Endo declines

By Cristal Cody

Tupelo, Miss., July 30 – China Evergrande Group’s bonds continued to plunge on Friday following the company’s downgrade at the start of the week by S&P Global Ratings.

China Evergrande’s 10% senior notes due 2023 (B3/CCC+) dropped 4½ points to 43½ bid during the session and headed out down more than 14 points on the week, a source said.

“China markets were again the worst performers this week with A shares off by 6% and credit distress ratio rising to 16%,” according to a BofA Securities, Inc. research note on Friday.

In other distressed secondary trading, Peabody Energy Corp.’s 6 3/8% senior secured notes due 2025 (Caa1/D) added ½ point to the 79½ bid area, about 6 points better on the week.

Washington Prime Group, LP’s 6.45% notes due 2024 (C/D/CC) traded mostly flat at 61¼ bid.

In the distressed pharmaceuticals space, bonds from Endo International plc pulled back on Friday after the paper soared in the previous week following the announcement of a $35 million opioid-related settlement.

Endo Finance LLC’s 6% senior notes due 2028 (Caa2/CCC+) fell 3/8 point to 67¾ bid, a source said.

Mallinckrodt LLC’s 5¾% notes due 2022 were quoted at 66 bid, ½ point better on the week.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.